Navigation Links
Susan G. Komen for the Cure(R) Advocacy Alliance Responds to President Barack Obama's Address to Congress
Date:2/24/2009

'Discovering and Delivering the Cures to Cancer Must Be a Top National Priority'

WASHINGTON, Feb. 24 /PRNewswire/ -- Martina Hone, president of the Susan G. Komen for the Cure(R) Advocacy Alliance, issued the following statement in response to President Barack Obama's address to a joint session of Congress this evening:

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO)

"This is a critical time in our nation's history. We are confronted with large health care challenges. Yet the potential to significantly improve access to critical health care services for all and to make meaningful progress in discovering the cures to cancer provide us with the hope of an exciting and healthier future.

"We were grateful Congress and the Administration took the first step in addressing the growing health care crisis in the states with the recent economic stimulus legislation. These funds give states the opportunity to avoid cuts to potentially life-saving breast cancer education, screening and treatment services for underserved women.

"Yet there is so much more to do. As the non-partisan voice for over 2.5 million breast cancer survivors and the people who love them, we look forward to working with President Obama to establish a health system that ensures access to affordable, high-quality health care for all - including underserved populations and people with chronic or pre-existing conditions like cancer.

"We must ensure that everyone has access to breast cancer screening and treatment. For breast cancer, as is the case for many diseases, early detection is the closest thing we have to prevention. Detecting cancer early not only increases a patient's chance of survival, but also considerably reduces the cost of their treatment.

"We were also thankful for the considerable investment in health research contained in the stimulus legislation. We urge the Administration to intensify this commitment to discovering the cures, as funding has remained essentially flat since 2003. We must signal that discovering and delivering the cures for cancer is a top national priority."

The Susan G. Komen for the Cure Advocacy Alliance is a voice for change on Capitol Hill, in state legislatures and on the campaign trail. With the help of nearly 200,000 Komen Champions and Komen's network of 122 domestic affiliates, we are aggressively seeking increased funding for research and greater access to screening and treatment. The Komen Advocacy Alliance engages policymakers and leaders at all levels of government to advocate for an increased investment in breast cancer research and greater access to breast health services.


'/>"/>
SOURCE Susan G. Komen for the Cure(R) Advocacy Alliance
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Congress for Including Health Care Assistance; Research in Economic Stimulus
2. Dr Pepper Snapple Group Product Goes Pink in Support of Susan G. Komen for the Cure(R)
3. New Balance Celebrates the 20th Anniversary of Susan G. Komen for the Cure(R) Partnership
4. Virgin Mobile USA Launches Limited Edition Pink Flare Handset to Benefit Susan G. Komen for the Cure(R)
5. Susan Lark, MD Continues to Urge Women to Fight for Their Right to Use Bioidentical Hormones
6. Susan G. Komen for the Cure(R) and Triple Negative Breast Cancer Foundation Unite to Fight Aggressive Form of Breast Cancer
7. Susan Knapp Pinnas Named AvMed Health Plans New Senior Vice President of Network
8. Dr. Susan Lark's Squalane Now Made From Olives, Not Sharks
9. Susan Lark, MD Urges Women to Fight for Their Right to Use Bioidentical Hormones
10. Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Selection of Senator Tom Daschle for HHS Secretary, White House Health Reform Czar
11. Susan G. Komen for the Cure(R) Announces Recipients of 2008 Komen Brinker Award for Scientific Distinction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , ... December 05, 2016 , ... ... Plastic Surgery, is excited to announce the arrival of the newest Sciton laser ... with the ability to use tunable non-ablative and ablative wavelengths for exceptional results. ...
(Date:12/5/2016)... ... December 05, 2016 , ... SyncDog, Inc., the leading ... magazine, a leading online tech news platform connecting technology innovators with news, experience, ... explores the state of enterprise mobility security today, and how the SyncDog SentinelSecure™ ...
(Date:12/5/2016)... ... 05, 2016 , ... Worldwise ®, a leading consumer ... kathy ireland® Worldwide for five additional years, announced by Kevin Fick, Worldwise CEO. ... agreement three years ago to design and develop the kathy ireland® Loved Ones™ ...
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education Resource®, ... International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on February ... are honored to have Amy E. Herman present at this year’s conference, her ...
(Date:12/5/2016)... , ... December 05, 2016 , ... BSI and Brenntag ... United States and Canada for distribution of their natural fruits and beverage ... is an exciting addition to our Life Sciences product portfolio,” said Steve Brauer, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... United Kingdom , Dec. 5, 2016   ... leading global specialty pharmaceutical company, today announced that it ... 2017 Corporate Equality Index (CEI), a national benchmarking survey ... lesbian, gay, bisexual and transgender (LGBT) workplace equality, administered ... the ranks of 517 major U.S. businesses which also ...
(Date:12/5/2016)... Dec. 5, 2016  Parallax Health Sciences, Inc. ("Parallax" ... announce that its pharmaceutical business, RoxSan Pharmacy, Inc. has ... coverage in all of the 42 states it is ... Michael Rashti Pharm . D, Pharmacist in Charge ... for our business. Medicare B spending last year came ...
(Date:12/5/2016)... Research and Markets has announced the addition of the ... Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & ... offering. ... The western blotting market is expected ... in 2016, growing at a CAGR of 4.9%. ...
Breaking Medicine Technology: